{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:02:59Z","timestamp":1786982579669,"version":"build-2736575974"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s13205-023-03553-8","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T05:04:42Z","timestamp":1682571882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["An update on pathogenesis and clinical scenario for Parkinson\u2019s disease: diagnosis and treatment"],"prefix":"10.1007","volume":"13","author":[{"given":"Hussaini","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-4687","authenticated-orcid":false,"given":"Subash C. B.","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Md Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijjani","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Parmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irzaman","family":"Husein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uda","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"3553_CR1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/ars.2014.5994","volume":"22","author":"JM Abais","year":"2015","unstructured":"Abais JM, Xia M, Zhang Y et al (2015) Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal 22:1111\u20131129. https:\/\/doi.org\/10.1089\/ars.2014.5994","journal-title":"Antioxid Redox Signal"},{"key":"3553_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.32598\/bcn.12.6.88.7","volume":"12","author":"GF Acidic","year":"2021","unstructured":"Acidic GF (2021) Research paper: paeonol protection against intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease. Basic Clin Neurosci 12:43\u201356","journal-title":"Basic Clin Neurosci"},{"key":"3553_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijbiomac.2021.01.014","volume":"171","author":"H Adam","year":"2021","unstructured":"Adam H, Gopinath SCB, Arshad MKM et al (2021) Distinguishing normal and aggregated alpha-synuclein interaction on gold nanorod incorporated zinc oxide nanocomposite by electrochemical technique. Int J Biol Macromol 171:217\u2013224. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.014","journal-title":"Int J Biol Macromol"},{"key":"3553_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/21691401.2017.1411930","volume":"46","author":"Z Aghili","year":"2018","unstructured":"Aghili Z, Nasirizadeh N, Divsalar A et al (2018) A highly sensitive miR-195 nanobiosensor for early detection of Parkinson\u2019s disease. Artif Cells Nanomed Biotechnol 46:32\u201340. https:\/\/doi.org\/10.1080\/21691401.2017.1411930","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3553_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1176\/appi.neuropsych.19030058","volume":"32","author":"MA Akkaoui","year":"2020","unstructured":"Akkaoui MA, Geoffroy PA, Roze E et al (2020) Functional motor symptoms in parkinson\u2019s disease and functional parkinsonism: a systematic review. J Neuropsychiatry Clin Neurosci 32:4\u201313. https:\/\/doi.org\/10.1176\/appi.neuropsych.19030058","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3553_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics13010069","volume":"13","author":"M Alothman","year":"2021","unstructured":"Alothman M, Ispas-Szabo P, Mateescu MA (2021) Design of catalase monolithic tablets for intestinal targeted delivery. Pharmaceutics 13:1\u201316. https:\/\/doi.org\/10.3390\/pharmaceutics13010069","journal-title":"Pharmaceutics"},{"key":"3553_CR7","unstructured":"Antiochia R (2020) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\u2019 s public news and information"},{"key":"3553_CR8","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1021\/acsnano.2c00054","volume":"16","author":"M Antman-Passig","year":"2022","unstructured":"Antman-Passig M, Wong E, Frost GR et al (2022) Optical nanosensor for intracellular and intracranial detection of amyloid-beta. ACS Nano 16:7269\u20137283. https:\/\/doi.org\/10.1021\/acsnano.2c00054","journal-title":"ACS Nano"},{"key":"3553_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s13311-020-00889-4","volume":"17","author":"SD Aradi","year":"2020","unstructured":"Aradi SD, Hauser RA (2020) Medical management and prevention of motor complications in Parkinson\u2019s disease. Neurotherapeutics 17:1339\u20131365. https:\/\/doi.org\/10.1007\/s13311-020-00889-4","journal-title":"Neurotherapeutics"},{"key":"3553_CR10","doi-asserted-by":"publisher","DOI":"10.1063\/5.0022211","author":"A Asghari","year":"2021","unstructured":"Asghari A, Wang C, Yoo KM et al (2021) Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: opportunities and challenges. Appl Phys Rev. https:\/\/doi.org\/10.1063\/5.0022211","journal-title":"Appl Phys Rev"},{"key":"3553_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"AM Association","year":"2020","unstructured":"Association AM (2020) Diagnosis and treatment of parkinson disease: a review. JAMA 323:548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"3553_CR12","doi-asserted-by":"crossref","unstructured":"Attaallah R, Antonacci A, Arduini F, et al (2020) Nanobiosensors for bioclinical applications: pros and cons","DOI":"10.1007\/978-3-030-39246-8_5"},{"key":"3553_CR13","doi-asserted-by":"publisher","first-page":"14772","DOI":"10.1021\/acsomega.2c00145","volume":"7","author":"M Ayaz","year":"2022","unstructured":"Ayaz M, Anwar F, Saleem U et al (2022) Parkinsonism attenuation by antihistamines via downregulating the oxidative stress, histamine, and inflammation. ACS Omega 7:14772\u201314783. https:\/\/doi.org\/10.1021\/acsomega.2c00145","journal-title":"ACS Omega"},{"key":"3553_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00218","author":"N Ball","year":"2019","unstructured":"Ball N, Teo WP, Chandra S, Chapman J (2019) Parkinson\u2019s disease and the environment. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Front Neurol"},{"key":"3553_CR15","doi-asserted-by":"publisher","DOI":"10.1088\/1757-899X\/805\/1\/012028","author":"AT Banigo","year":"2020","unstructured":"Banigo AT, Azeez TO, Ejeta KO et al (2020) Nanobiosensors: applications in biomedical technology. IOP Conf Ser. https:\/\/doi.org\/10.1088\/1757-899X\/805\/1\/012028","journal-title":"IOP Conf Ser"},{"key":"3553_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/mdc3.13347","volume":"8","author":"MJ Barrett","year":"2021","unstructured":"Barrett MJ, Sargent L, Nawaz H et al (2021) Antimuscarinic anticholinergic medications in Parkinson disease: to prescribe or deprescribe? Movement Disord Clin Pract 8:1181\u20131188. https:\/\/doi.org\/10.1002\/mdc3.13347","journal-title":"Movement Disord Clin Pract"},{"key":"3553_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010210","author":"J Blasiak","year":"2019","unstructured":"Blasiak J, Pawlowska E, Szczepanska J, Kaarniranta K (2019) Interplay between autophagy and the ubiquitin-proteasome system and its role in the pathogenesis of age-related macular degeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20010210","journal-title":"Int J Mol Sci"},{"key":"3553_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071476","author":"RJ Boado","year":"2022","unstructured":"Boado RJ (2022) IgG fusion proteins for brain delivery of biologics via blood-brain barrier receptor-mediated transport. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14071476","journal-title":"Pharmaceutics"},{"key":"3553_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/s18051319","author":"P Bollella","year":"2018","unstructured":"Bollella P, Gorton L, Antiochia R (2018) Direct electron transfer of dehydrogenases for development of 3rd generation biosensors and enzymatic fuel cells. Sensors (switzerland). https:\/\/doi.org\/10.3390\/s18051319","journal-title":"Sensors (switzerland)"},{"key":"3553_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/198316","author":"AM Bonnet","year":"2012","unstructured":"Bonnet AM, Jutras MF, Czernecki V et al (2012) Nonmotor symptoms in Parkinsons disease in 2012: relevant clinical aspects. Parkinson\u2019s Dis. https:\/\/doi.org\/10.1155\/2012\/198316","journal-title":"Parkinson\u2019s Dis"},{"key":"3553_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40263-019-00661-z","volume":"33","author":"F Carbone","year":"2019","unstructured":"Carbone F, Djamshidian A, Seppi K, Poewe W (2019) Apomorphine for Parkinson\u2019s disease: efficacy and safety of current and new formulations. CNS Drugs 33:905\u2013918. https:\/\/doi.org\/10.1007\/s40263-019-00661-z","journal-title":"CNS Drugs"},{"key":"3553_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox9070597","volume":"9","author":"KH Chang","year":"2020","unstructured":"Chang KH, Chen CM (2020) The role of oxidative stress in Parkinson\u2019s disease. Antioxidants 9:1\u201332. https:\/\/doi.org\/10.3390\/antiox9070597","journal-title":"Antioxidants"},{"key":"3553_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biology8020038","volume":"8","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK (2019) Mitochondrial dysfunction in Parkinson\u2019s disease\u2014cause or consequence? Biology 8:1\u201326. https:\/\/doi.org\/10.3390\/biology8020038","journal-title":"Biology"},{"key":"3553_CR24","volume-title":"Anti - Parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials","author":"G Cheng","year":"2022","unstructured":"Cheng G, Liu Y, Ma R et al (2022) Anti - Parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials. Springer, Singapore"},{"key":"3553_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/bios13010131","volume":"13","author":"L Cheng","year":"2023","unstructured":"Cheng L, Hao X, Liu G et al (2023) A flexible pressure sensor based on silicon nanomembrane. Biosensors 13:131. https:\/\/doi.org\/10.3390\/bios13010131","journal-title":"Biosensors"},{"key":"3553_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152416","author":"WM Curtis","year":"2022","unstructured":"Curtis WM, Seeds WA, Mattson MP, Bradshaw PC (2022) NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells11152416","journal-title":"Cells"},{"key":"3553_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-022-00559-6","author":"SS Dahbour","year":"2022","unstructured":"Dahbour SS, Al Murr MJ, Oweis LH et al (2022) Non-motor manifestation of Parkinson\u2019s disease: a cross-sectional study in a teaching hospital in Jordan. Egypt J Neurol Psychiatry Neurosurg. https:\/\/doi.org\/10.1186\/s41983-022-00559-6","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"3553_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071006","author":"JO Day","year":"2021","unstructured":"Day JO, Mullin S (2021) The genetics of parkinson\u2019s disease and implications for clinical practice. Genes. https:\/\/doi.org\/10.3390\/genes12071006","journal-title":"Genes"},{"key":"3553_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14:32","journal-title":"Mol Neurodegener"},{"issue":"4","key":"3553_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/electronics12040783","volume":"12","author":"S Dixit","year":"2023","unstructured":"Dixit S, Bohre K, Singh Y et al (2023) A Comprehensive review on AI-enabled models for Parkinson\u2019s disease diagnosis. Electronics 12(4):783","journal-title":"Electronics"},{"key":"3553_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01353-3","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X et al (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Targeted Ther. https:\/\/doi.org\/10.1038\/s41392-023-01353-3","journal-title":"Signal Transduct Targeted Ther"},{"key":"3553_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/bios13010144","volume":"13","author":"A Erdem","year":"2023","unstructured":"Erdem A, Eksin E (2023) Zip nucleic acid-based genomagnetic assay for electrochemical detection of microRNA-34a. Biosensors 13:1\u201314. https:\/\/doi.org\/10.3390\/bios13010144","journal-title":"Biosensors"},{"key":"3553_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosx.2022.100270","volume":"12","author":"C Erkmen","year":"2022","unstructured":"Erkmen C, Selcuk O, Unal DN et al (2022) Layer-by-layer modification strategies for electrochemical detection of biomarkers. Biosens Bioelectron 12:100270. https:\/\/doi.org\/10.1016\/j.biosx.2022.100270","journal-title":"Biosens Bioelectron"},{"key":"3553_CR34","doi-asserted-by":"publisher","DOI":"10.1021\/acssensors.0c02704","author":"S Fruncillo","year":"2021","unstructured":"Fruncillo S, Su X, Liu H, Wong LS (2021) Lithographic processes for the scalable fabrication of micro- and nano-structures for biochips and biosensors. ACS Sens. https:\/\/doi.org\/10.1021\/acssensors.0c02704","journal-title":"ACS Sens"},{"key":"3553_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/s20144022","volume":"20","author":"V Gajdosova","year":"2020","unstructured":"Gajdosova V, Lorencova L, Kasak P, Tkac J (2020) Electrochemical nanobiosensors for detection of breast cancer biomarkers. Sensors (switzerland) 20:1\u201337. https:\/\/doi.org\/10.3390\/s20144022","journal-title":"Sensors (switzerland)"},{"key":"3553_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/MOLECULES26010214","volume":"26","author":"M Gajek","year":"2021","unstructured":"Gajek M, Pawlaczyk A, Szynkowska-Jozwik MI (2021) Multi-elemental analysis of wine samples in relation to their type, origin, and grape variety. Molecules 26:1\u201326. https:\/\/doi.org\/10.3390\/MOLECULES26010214","journal-title":"Molecules"},{"key":"3553_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.702639","volume":"13","author":"U Ganguly","year":"2021","unstructured":"Ganguly U, Singh S, Pal S et al (2021) Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough. Front Aging Neurosci 13:1\u201319. https:\/\/doi.org\/10.3389\/fnagi.2021.702639","journal-title":"Front Aging Neurosci"},{"key":"3553_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2021.626128","volume":"15","author":"NZ Gcwensa","year":"2021","unstructured":"Gcwensa NZ, Russell DL, Cowell RM, Volpicelli-Daley LA (2021) Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease. Front Cell Neurosci 15:1\u201315. https:\/\/doi.org\/10.3389\/fncel.2021.626128","journal-title":"Front Cell Neurosci"},{"key":"3553_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","author":"V Ghiglieri","year":"2023","unstructured":"Ghiglieri V (2023) Alpha-synuclein in Parkinson \u2019 s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dise. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dise"},{"key":"3553_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"M G\u00f3mez-Benito","year":"2020","unstructured":"G\u00f3mez-Benito M, Granado N, Garc\u00eda-Sanz P et al (2020) Modeling Parkinson\u2019s disease with the alpha-synuclein protein. Front Pharmacol 11:1\u201315. https:\/\/doi.org\/10.3389\/fphar.2020.00356","journal-title":"Front Pharmacol"},{"key":"3553_CR41","doi-asserted-by":"publisher","first-page":"185a","DOI":"10.1016\/j.bpj.2017.11.1031","volume":"114","author":"RG Griffin","year":"2018","unstructured":"Griffin RG (2018) Symposium: fibril assembly and structure: progress and challenges symposium: biophysics of lipid-modified GTPases. Biophysj 114:185a","journal-title":"Biophysj"},{"key":"3553_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4274\/tjps.galenos.2021.95226","volume":"19","author":"M G\u00fcne\u015f","year":"2022","unstructured":"G\u00fcne\u015f M (2022) Non-oral drug delivery in Parkinson\u2019s disease: current applications and future. Turkish J Pharm Sci 19:343\u2013352. https:\/\/doi.org\/10.4274\/tjps.galenos.2021.95226","journal-title":"Turkish J Pharm Sci"},{"key":"3553_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68874-7","author":"MJ Haney","year":"2020","unstructured":"Haney MJ, Zhao Y, Fay J et al (2020) Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X (A) mice: importance of administration routes. Sci Reports. https:\/\/doi.org\/10.1038\/s41598-020-68874-7","journal-title":"Sci Reports"},{"key":"3553_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/s22197581","author":"A Hannon","year":"2022","unstructured":"Hannon A, Seames W, Li J (2022) Hybrid carbon nanotubes\/gold nanoparticles composites for trace nitric oxide detection over a wide range of humidity. Sensors. https:\/\/doi.org\/10.3390\/s22197581","journal-title":"Sensors"},{"key":"3553_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419838096","author":"CJ Hartmann","year":"2019","unstructured":"Hartmann CJ, Schnitzler A, Fliegen S et al (2019) An update on best practice of deep brain stimulation in Parkinson \u2019 s disease. Ther Adv Neurol Disord. https:\/\/doi.org\/10.1177\/1756286419838096","journal-title":"Ther Adv Neurol Disord"},{"key":"3553_CR46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/00325481.2021.1936087","volume":"133","author":"RA Hauser","year":"2021","unstructured":"Hauser RA, Lewitt PA, Comella CL et al (2021) On demand therapy for Parkinson \u2019 s disease patients: opportunities and choices. Postgrad Med 133:721\u2013727. https:\/\/doi.org\/10.1080\/00325481.2021.1936087","journal-title":"Postgrad Med"},{"key":"3553_CR47","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jmrt.2021.03.048","volume":"12","author":"X Huang","year":"2021","unstructured":"Huang X, Zhu Y, Kianfar E (2021a) Nano Biosensors: properties, applications and electrochemical techniques. J Market Res 12:1649\u20131672. https:\/\/doi.org\/10.1016\/j.jmrt.2021.03.048","journal-title":"J Market Res"},{"key":"3553_CR48","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jmrt.2021.03.048","volume":"12","author":"X Huang","year":"2021","unstructured":"Huang X, Zhu Y, Kianfar E (2021b) Nano Biosensors: properties, applications and electrochemical techniques. J Market Res 12:1649\u20131672. https:\/\/doi.org\/10.1016\/j.jmrt.2021.03.048","journal-title":"J Market Res"},{"key":"3553_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s13534-021-00204-w","volume":"11","author":"J Hyun","year":"2021","unstructured":"Hyun J, Young K, Suh J et al (2021) Technological advances in electrochemical biosensors for the detection of disease biomarkers. Biomed Eng Lett 11:309\u2013334. https:\/\/doi.org\/10.1007\/s13534-021-00204-w","journal-title":"Biomed Eng Lett"},{"key":"3553_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/bios12080581","author":"RE Ionescu","year":"2022","unstructured":"Ionescu RE (2022) Use of cysteamine and glutaraldehyde chemicals for robust functionalization of substrates with protein biomarkers\u2014an overview on the construction of biosensors with different transductions. Biosensors. https:\/\/doi.org\/10.3390\/bios12080581","journal-title":"Biosensors"},{"key":"3553_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.528809","volume":"14","author":"J Ivanidze","year":"2020","unstructured":"Ivanidze J, Skafida M, Pandya S et al (2020) Molecular imaging of striatal dopaminergic neuronal loss and the neurovascular unit in Parkinson disease. Front Neurosci 14:1\u20139. https:\/\/doi.org\/10.3389\/fnins.2020.528809","journal-title":"Front Neurosci"},{"key":"3553_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10050832","volume":"10","author":"SJ Jang","year":"2020","unstructured":"Jang SJ, Lee CS, Kim TH (2020) \u03b1-Synuclein oligomer detection with aptamer switch on reduced graphene oxide electrode. Nanomaterials 10:1\u201311. https:\/\/doi.org\/10.3390\/nano10050832","journal-title":"Nanomaterials"},{"issue":"8","key":"3553_CR54","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020a) Hindsight Parkinson \u2019 s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3553_CR55","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020b) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91:795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3553_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01061-1","volume-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease","author":"T Kamath","year":"2022","unstructured":"Kamath T, Abdulraouf A, Burris SJ et al (2022) Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Springer"},{"key":"3553_CR57","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan I, Saeed K, Khan I (2019) Nanoparticles: properties, applications and toxicities. Arab J Chem 12:908\u2013931. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.011","journal-title":"Arab J Chem"},{"issue":"1","key":"3553_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40824-017-0112-8","volume":"1","author":"HS Kim","year":"2023","unstructured":"Kim HS, Park SC, Kim HJ, Lee DY (2023) Inhibition of DAMP actions in the tumoral microenvironment using lactoferrin-glycyrrhizin nanoconjugate for glioblastoma therapy. Biomaterials Res 1(1):1\u201336","journal-title":"Biomaterials Res"},{"issue":"5402","key":"3553_CR59","first-page":"1","volume":"20","author":"K Kin","year":"2019","unstructured":"Kin K, Yasuhara T, Kameda M, Date I (2019) Animal models for Parkinson\u2019s disease research: trends in the 2000s. Int J Mol Sci 20(5402):1\u201314","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3553_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/JSEN.2020.3039123","volume":"21","author":"A Koyappayil","year":"2021","unstructured":"Koyappayil A, Lee M (2021) Ultrasensitive materials for electrochemical biosensor labels. Sensors 21(1):1\u201320","journal-title":"Sensors"},{"issue":"2","key":"3553_CR61","first-page":"75","volume":"17","author":"JK Krauss","year":"2021","unstructured":"Krauss JK, Lipsman N, Aziz T et al (2021) Technology of deep brain stimulation: current status and future directions. Europe PMC 17(2):75\u201387","journal-title":"Europe PMC"},{"key":"3553_CR62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3934\/Neuroscience.2019.4.333","volume":"6","author":"MG Krokidis","year":"2019","unstructured":"Krokidis MG (2019) Identification of biomarkers associated with Parkinson\u2019s disease by gene expression profiling studies and bioinformatics analysis. AIMS Neurosci 6:333\u2013345. https:\/\/doi.org\/10.3934\/Neuroscience.2019.4.333","journal-title":"AIMS Neurosci"},{"key":"3553_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/bios13010085","author":"S Kumar","year":"2023","unstructured":"Kumar S, Wang Z, Zhang W et al (2023) Optically active nanomaterials and its biosensing applications\u2014a review. Biosensors. https:\/\/doi.org\/10.3390\/bios13010085","journal-title":"Biosensors"},{"key":"3553_CR64","unstructured":"Lakard S, Pavel I, Lakard B, et al (2022) Electrochemical biosensing of dopamine neurotransmitter: a review to cite this version\u202f: HAL Id\u202f: hal-03573345 electrochemical biosensing of dopamine neurotransmitter: a review. 0\u201323"},{"key":"3553_CR65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.20517\/2347-8659.2020.58","volume":"8","author":"TK Lee","year":"2021","unstructured":"Lee TK, Yankee EL (2021) A review on Parkinson\u2019s disease treatment. Neuroimmunol Neuroinflamm 8:222\u2013244. https:\/\/doi.org\/10.20517\/2347-8659.2020.58","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"3553_CR66","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2147\/IJN.S243223","volume":"15","author":"J Li","year":"2020","unstructured":"Li J, Zhao J, Tan T et al (2020) Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review. Int J Nanomed 15:2563\u20132582. https:\/\/doi.org\/10.2147\/IJN.S243223","journal-title":"Int J Nanomed"},{"key":"3553_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.surfin.2021.101375","volume":"26","author":"F Li","year":"2021","unstructured":"Li F, Ni B, Zheng Y et al (2021a) A simple and efficient voltammetric sensor for dopamine determination based on ZnO nanorods\/electro-reduced graphene oxide composite. Surf Interfaces 26:101375. https:\/\/doi.org\/10.1016\/j.surfin.2021.101375","journal-title":"Surf Interfaces"},{"key":"3553_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2021.797833","volume":"14","author":"JL Li","year":"2021","unstructured":"Li JL, Lin TY, Chen PL et al (2021b) Mitochondrial function and Parkinson\u2019s disease: from the perspective of the electron transport chain. Front Mol Neurosci 14:1\u201315. https:\/\/doi.org\/10.3389\/fnmol.2021.797833","journal-title":"Front Mol Neurosci"},{"key":"3553_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/bios11070214","author":"B Lin","year":"2021","unstructured":"Lin B, Hui J, Mao H (2021) Nanopore technology and its applications in gene sequencing. Biosensors. https:\/\/doi.org\/10.3390\/bios11070214","journal-title":"Biosensors"},{"key":"3553_CR70","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41380-021-01394-6","volume":"27","author":"P Lindholm","year":"2022","unstructured":"Lindholm P, Saarma M (2022) Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Mol Psychiatry 27:1310\u20131321. https:\/\/doi.org\/10.1038\/s41380-021-01394-6","journal-title":"Mol Psychiatry"},{"key":"3553_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/s19071619","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yao L, He L et al (2019) Electrochemical enzyme biosensor bearing biochar nanoparticle as signal enhancer for bisphenol a detection in water. Sensors (switzerland). https:\/\/doi.org\/10.3390\/s19071619","journal-title":"Sensors (switzerland)"},{"key":"3553_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.00979","volume":"11","author":"K Long","year":"2020","unstructured":"Long K, Wan C, Xiang Y et al (2020) Study on the clinical features of Parkinson\u2019s disease with probable rapid eye movement sleep behavior disorder. Front Neurol 11:1\u201310. https:\/\/doi.org\/10.3389\/fneur.2020.00979","journal-title":"Front Neurol"},{"key":"3553_CR73","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41582-018-0128-2","volume":"15","author":"AM Lozano","year":"2019","unstructured":"Lozano AM, Lipsman N, Bergman H et al (2019) Deep brain stimulation: current challenges and future directions. Nat Rev Neurol 15:148\u2013160. https:\/\/doi.org\/10.1038\/s41582-018-0128-2","journal-title":"Nat Rev Neurol"},{"key":"3553_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14802\/jmd.20079","volume":"14","author":"M Lubomski","year":"2021","unstructured":"Lubomski M, Davis RL, Sue CM (2021) Health-related quality of life for parkinson\u2019s disease patients and their caregivers. J Movement Disord 14:42\u201352. https:\/\/doi.org\/10.14802\/jmd.20079","journal-title":"J Movement Disord"},{"key":"3553_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum.2021.667035","volume":"15","author":"A Mahajan","year":"2021","unstructured":"Mahajan A, Butala A, Okun MS et al (2021) Global variability in deep brain stimulation practices for Parkinson\u2019s disease. Front Hum Neurosci 15:1\u201312. https:\/\/doi.org\/10.3389\/fnhum.2021.667035","journal-title":"Front Hum Neurosci"},{"key":"3553_CR76","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"AL Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier AL, Burtscher J, Maharjan N et al (2020) The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci USA 117:4971\u20134982. https:\/\/doi.org\/10.1073\/pnas.1913904117","journal-title":"Proc Natl Acad Sci USA"},{"key":"3553_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.18502\/kls.v7i1.10152","volume":"2022","author":"T Malankhanova","year":"2022","unstructured":"Malankhanova T, Vasileva D, Grigor\u2019eva E et al (2022) Oxidative stress research on huntington\u2019s disease neurons using genetically encoded biosensors. KnE Life Sci 2022:424\u2013434. https:\/\/doi.org\/10.18502\/kls.v7i1.10152","journal-title":"KnE Life Sci"},{"key":"3553_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00273-9","author":"K Men\u0161\u00edkov\u00e1","year":"2022","unstructured":"Men\u0161\u00edkov\u00e1 K, Mat\u011bj R, Colosimo C et al (2022) Lewy body disease or diseases with Lewy bodies? NPJ Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/s41531-021-00273-9","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"3553_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.580634","volume":"8","author":"G Minakaki","year":"2020","unstructured":"Minakaki G, Krainc D, Burbulla LF (2020) The convergence of lysosomal pathways in vulnerability of midbrain dopaminergic neurons in Parkinson\u2019s disease. Front Cell Dev Biol 8:1\u201315. https:\/\/doi.org\/10.3389\/fcell.2020.580634","journal-title":"Front Cell Dev Biol"},{"key":"3553_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0090-8","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM et al (2021) Engineering precision nanoparticles. Nat Rev Drug Discovery. https:\/\/doi.org\/10.1038\/s41573-020-0090-8","journal-title":"Nat Rev Drug Discovery"},{"key":"3553_CR81","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1515\/tnsci-2022-0258","volume":"13","author":"KR Mittal","year":"2022","unstructured":"Mittal KR, Pharasi N, Sarna B et al (2022) Nanotechnology-based drug delivery for the treatment of CNS disorders. Transl Neurosci 13:527\u2013546. https:\/\/doi.org\/10.1515\/tnsci-2022-0258","journal-title":"Transl Neurosci"},{"issue":"3","key":"3553_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/bios9030086","volume":"9","author":"F Mollarasouli","year":"2019","unstructured":"Mollarasouli F, Kurbanoglu S, Ozkan SA (2019) The role of electrochemical immunosensors in clinical analysis. Biosensors 9(3):1\u201319. https:\/\/doi.org\/10.3390\/bios9030086","journal-title":"Biosensors"},{"key":"3553_CR82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/c8040050","volume":"8","author":"H Moradpour","year":"2022","unstructured":"Moradpour H, Beitollahi H (2022) Simultaneous electrochemical sensing of dopamine, ascorbic acid, and uric acid using nitrogen-doped graphene sheet-modified glassy carbon electrode. C 8:50. https:\/\/doi.org\/10.3390\/c8040050","journal-title":"C"},{"issue":"2","key":"3553_CR83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmedgenet-2019-106210","volume":"57","author":"L Mou","year":"2020","unstructured":"Mou L, Ding W, Fernandez- P (2020) Open questions on the nature of Parkinson\u2019s disease: from triggers to spreading pathology. J Med Genet 57(2):73\u201381. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106210","journal-title":"J Med Genet"},{"key":"3553_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81185-9","volume-title":"Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration","author":"VR Muddapu","year":"2021","unstructured":"Muddapu VR, Chakravarthy VS (2021) Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration. Nature Publishing Group"},{"key":"3553_CR85","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/JEP.S267032","volume":"13","author":"T M\u00fcller","year":"2021","unstructured":"M\u00fcller T (2021) Experimental dopamine reuptake inhibitors in parkinson\u2019s disease: a review of the evidence. J Exp Pharmacol 13:397\u2013408. https:\/\/doi.org\/10.2147\/JEP.S267032","journal-title":"J Exp Pharmacol"},{"key":"3553_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.00494","volume":"14","author":"S Naqvi","year":"2020","unstructured":"Naqvi S, Panghal A, Flora SJS (2020) Nanotechnology: a promising approach for delivery of neuroprotective drugs. Front Neurosci 14:1\u201326. https:\/\/doi.org\/10.3389\/fnins.2020.00494","journal-title":"Front Neurosci"},{"key":"3553_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/s21041109","volume":"21","author":"V Naresh","year":"2021","unstructured":"Naresh V, Lee N (2021) A review on biosensors and recent development of nanostructured materials-enabled biosensors. Sensors (switzerland) 21:1\u201335. https:\/\/doi.org\/10.3390\/s21041109","journal-title":"Sensors (switzerland)"},{"key":"3553_CR88","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1515\/nanoph-2022-0354","volume":"11","author":"G Nava","year":"2022","unstructured":"Nava G, Zanchetta G, Giavazzi F, Buscaglia M (2022) Label-free optical biosensors in the pandemic era. Nanophotonics 11:4159\u20134181. https:\/\/doi.org\/10.1515\/nanoph-2022-0354","journal-title":"Nanophotonics"},{"key":"3553_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2021.629832","volume":"9","author":"EE Ngowi","year":"2021","unstructured":"Ngowi EE, Wang Y, Qian L (2021) The application of nanotechnology for the diagnosis and treatment of brain diseases and disorders. Front Bioeng Biotechnol 9:1\u201319. https:\/\/doi.org\/10.3389\/fbioe.2021.629832","journal-title":"Front Bioeng Biotechnol"},{"key":"3553_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/bios12040251","volume":"12","author":"X Niu","year":"2022","unstructured":"Niu X, Liu B, Hu P et al (2022) Nanozymes with multiple activities: prospects in analytical sensing. Biosensors 12:1\u201321. https:\/\/doi.org\/10.3390\/bios12040251","journal-title":"Biosensors"},{"key":"3553_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00279-2","author":"T Ntetsika","year":"2021","unstructured":"Ntetsika T, Papathoma PE, Markaki I (2021) Novel targeted therapies for Parkinson\u2019s disease. Mol Med. https:\/\/doi.org\/10.1186\/s10020-021-00279-2","journal-title":"Mol Med"},{"key":"3553_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D et al (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:1\u201318. https:\/\/doi.org\/10.1186\/s13024-019-0306-8","journal-title":"Mol Neurodegener"},{"key":"3553_CR93","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5152\/TJAR.2018.56255","volume":"46","author":"O \u00d6zl\u00fc","year":"2018","unstructured":"\u00d6zl\u00fc O (2018) Anaesthesiologist\u2019s approach to awake craniotomy. Turk Anesteziyoloji Ve Reanimasyon Dernegi Dergisi 46:250\u2013256. https:\/\/doi.org\/10.5152\/TJAR.2018.56255","journal-title":"Turk Anesteziyoloji Ve Reanimasyon Dernegi Dergisi"},{"key":"3553_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213445","author":"FJ Padilla-God\u00ednez","year":"2022","unstructured":"Padilla-God\u00ednez FJ, Ruiz-Ortega LI, Guerra-Crespo M (2022) Nanomedicine in the face of Parkinson\u2019s disease: from drug delivery systems to nanozymes. Cells. https:\/\/doi.org\/10.3390\/cells11213445","journal-title":"Cells"},{"key":"3553_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105719","volume":"169","author":"D Pamies","year":"2022","unstructured":"Pamies D, Wiersma D, Katt ME et al (2022) Human organotypic brain model as a tool to study chemical-induced dopaminergic neuronal toxicity. Neurobiol Dis 169:105719. https:\/\/doi.org\/10.1016\/j.nbd.2022.105719","journal-title":"Neurobiol Dis"},{"key":"3553_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fsens.2022.789771","volume":"3","author":"N Pandey","year":"2022","unstructured":"Pandey N, Biswas D, Dutta N et al (2022) Sensing soluble immune checkpoint molecules and disease-relevant cytokines in cancer: a novel paradigm in disease diagnosis and monitoring. Front Sens 3:1\u201320. https:\/\/doi.org\/10.3389\/fsens.2022.789771","journal-title":"Front Sens"},{"key":"3553_CR97","first-page":"1","volume":"9","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu H et al (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 9:1\u201311","journal-title":"Transl Neurodegener"},{"key":"3553_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78418-8","volume":"10","author":"A Papadopoulos","year":"2020","unstructured":"Papadopoulos A, Iakovakis D, Klingelhoefer L et al (2020) Unobtrusive detection of Parkinson\u2019s disease from multi-modal and in-the-wild sensor data using deep learning techniques. Sci Rep 10:1\u201313. https:\/\/doi.org\/10.1038\/s41598-020-78418-8","journal-title":"Sci Rep"},{"key":"3553_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmedt.2020.602236","volume":"2","author":"WM Pardridge","year":"2020","unstructured":"Pardridge WM (2020) Brain delivery of nanomedicines: trojan horse liposomes for plasmid DNA gene therapy of the brain. Front Med Technol 2:1\u201340. https:\/\/doi.org\/10.3389\/fmedt.2020.602236","journal-title":"Front Med Technol"},{"issue":"19","key":"3553_CR100","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.3390\/s22197539","volume":"22","author":"F Perspectives","year":"2022","unstructured":"Perspectives F (2022) Advances in electrochemical nano-biosensors for biomedical and environmental applications. Sensors 22(19):7539","journal-title":"Sensors"},{"key":"3553_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100061","volume":"3","author":"BJ Peterson","year":"2020","unstructured":"Peterson BJ, Rocca WA, Bower JH et al (2020) Clinical Parkinsonism and related disorders identifying incident Parkinson \u2019 s disease using administrative diagnostic codes: a validation study. Clin Parkinsonism Relat Disord 3:100061. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100061","journal-title":"Clin Parkinsonism Relat Disord"},{"key":"3553_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A, Calvani R, Coelho-J\u00fanior HJ et al (2020) Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration. Antioxidants 9:1\u201321. https:\/\/doi.org\/10.3390\/antiox9080647","journal-title":"Antioxidants"},{"key":"3553_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111654","author":"RGR Pinheiro","year":"2021","unstructured":"Pinheiro RGR, Coutinho AJ, Pinheiro M, Neves AR (2021) Nanoparticles for targeted brain drug delivery: What do we know? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111654","journal-title":"Int J Mol Sci"},{"key":"3553_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/bios12060385","author":"EO Polat","year":"2022","unstructured":"Polat EO, Tabak AF, Guven EB, Uysal BO (2022) Transducer technologies for biosensors and their wearable applications. Biosensors. https:\/\/doi.org\/10.3390\/bios12060385","journal-title":"Biosensors"},{"issue":"4","key":"3553_CR105","first-page":"1","volume":"1","author":"G Pontarollo","year":"2019","unstructured":"Pontarollo G, Acquasaliente L, Radu CM et al (2021) Human \u03b1-synuclein inhibits platelets aggregation in vitro by interfering with the \u03b1-thrombin\/protease-activated receptor 1 functional axis. BioRxiv 1(4):1\u201333","journal-title":"BioRxiv"},{"key":"3553_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.01019","volume":"12","author":"VM Pulgar","year":"2019","unstructured":"Pulgar VM (2019) Transcytosis to cross the blood brain barrier. New Adv Challenges 12:1\u20139. https:\/\/doi.org\/10.3389\/fnins.2018.01019","journal-title":"New Adv Challenges"},{"key":"3553_CR107","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/proteomes11010002","volume":"11","author":"A Punetha","year":"2023","unstructured":"Punetha A, Kotiya D (2023) Advancements in oncoproteomics technologies: treading toward translation into clinical practice. Proteomes 11:2. https:\/\/doi.org\/10.3390\/proteomes11010002","journal-title":"Proteomes"},{"key":"3553_CR108","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s00415-019-09382-1","volume":"267","author":"C Raccagni","year":"2020","unstructured":"Raccagni C, Nonnekes J, Bloem BR et al (2020) Gait and postural disorders in parkinsonism: a clinical approach. J Neurol 267:3169\u20133176. https:\/\/doi.org\/10.1007\/s00415-019-09382-1","journal-title":"J Neurol"},{"key":"3553_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2020.101752","volume":"104","author":"SN Rai","year":"2020","unstructured":"Rai SN, Singh P (2020) Advancement in the modelling and therapeutics of Parkinson\u2019s disease. J Chem Neuroanat 104:101752. https:\/\/doi.org\/10.1016\/j.jchemneu.2020.101752","journal-title":"J Chem Neuroanat"},{"key":"3553_CR110","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12640-019-00038-6","volume":"36","author":"SN Rai","year":"2019","unstructured":"Rai SN, Zahra W, Sen SS et al (2019) Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model. Neurotox Res 36:452\u2013462. https:\/\/doi.org\/10.1007\/s12640-019-00038-6","journal-title":"Neurotox Res"},{"key":"3553_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-020-02532-7","volume":"10","author":"SN Rai","year":"2020","unstructured":"Rai SN, Chaturvedi VK, Singh P et al (2020) Mucuna pruriens in Parkinson\u2019s and in some other diseases: recent advancement and future prospective. 3 Biotech 10:1\u201311. https:\/\/doi.org\/10.1007\/s13205-020-02532-7","journal-title":"3 Biotech"},{"key":"3553_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/v13071224","author":"M Rai","year":"2021","unstructured":"Rai M, Bonde S, Yadav A et al (2021a) Nanotechnology as a shield against covid-19: current advancement and limitations. Viruses. https:\/\/doi.org\/10.3390\/v13071224","journal-title":"Viruses"},{"key":"3553_CR113","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.4103\/1673-5374.306066","volume":"16","author":"SN Rai","year":"2021","unstructured":"Rai SN, Singh P, Varshney R et al (2021b) Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease. Neural Regen Res 16:1730\u20131739. https:\/\/doi.org\/10.4103\/1673-5374.306066","journal-title":"Neural Regen Res"},{"key":"3553_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2021.777347","volume":"15","author":"SN Rai","year":"2021","unstructured":"Rai SN, Tiwari N, Singh P et al (2021c) Therapeutic potential of vital transcription factors in Alzheimer\u2019s and Parkinson\u2019s disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci 15:1\u201320. https:\/\/doi.org\/10.3389\/fnins.2021.777347","journal-title":"Front Neurosci"},{"key":"3553_CR115","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3012778","author":"SN Rai","year":"2022","unstructured":"Rai SN, Tiwari N, Singh P et al (2022) Exploring the Paradox of COVID-19 in neurological complications with emphasis on Parkinson\u2019s and Alzheimer\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/3012778","journal-title":"Oxid Med Cell Longev"},{"key":"3553_CR116","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4103\/1673-5374.322430","volume":"17","author":"F Rey","year":"2022","unstructured":"Rey F, Ottolenghi S, Zuccotti G et al (2022) Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects. Neural Regen Res 17:754\u2013758. https:\/\/doi.org\/10.4103\/1673-5374.322430","journal-title":"Neural Regen Res"},{"key":"3553_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111897","author":"C Riccardi","year":"2021","unstructured":"Riccardi C, Napolitano F, Montesarchio D et al (2021) Nanoparticle-guided brain drug delivery: expanding the therapeutic approach to neurodegenerative diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13111897","journal-title":"Pharmaceutics"},{"key":"3553_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.00556","volume":"14","author":"P Rivero-r\u00edos","year":"2020","unstructured":"Rivero-r\u00edos P, Romo-lozano M, Fasiczka R, Naaldijk Y (2020) LRRK2-related Parkinson\u2019s disease due to altered endolysosomal biology with variable lewy body pathology: a hypothesis. Front Neurosci 14:1\u201316. https:\/\/doi.org\/10.3389\/fnins.2020.00556","journal-title":"Front Neurosci"},{"issue":"7","key":"3553_CR119","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/brainsci12070917","volume":"12","author":"MC Russillo","year":"2022","unstructured":"Russillo MC, Andreozzi V, Erro R et al (2022) Sex differences in Parkinson\u2019 s disease: from bench to bedside. Brain Sci 12(7):917","journal-title":"Brain Sci"},{"issue":"2","key":"3553_CR151","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gendis.2019.01.004","volume":"6","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj S, Piramanayagam S (2019) Impact of gene mutation in the development of Parkinson\u2019s disease. Genes Dis 6(2):120\u2013128. https:\/\/doi.org\/10.1016\/j.gendis.2019.01.004","journal-title":"Genes Dis"},{"key":"3553_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12938-022-01062-y","volume":"22","author":"L Shabani","year":"2023","unstructured":"Shabani L, Abbasi M, Azarnew Z et al (2023) Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience. Biomed Eng Online 22:1\u201341. https:\/\/doi.org\/10.1186\/s12938-022-01062-y","journal-title":"Biomed Eng Online"},{"key":"3553_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-021-03593-0","author":"P Sharma","year":"2021","unstructured":"Sharma P, Pandey V, Sharma MMM et al (2021) A review on biosensors and nanosensors application in agroecosystems. Nanoscale Res Lett. https:\/\/doi.org\/10.1186\/s11671-021-03593-0","journal-title":"Nanoscale Res Lett"},{"key":"3553_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.794580","volume":"12","author":"M Shi","year":"2022","unstructured":"Shi M, Chai Y, Zhang J, Chen X (2022) Endoplasmic reticulum stress-associated neuronal death and innate immune response in neurological diseases. Front Immunol 12:1\u201326. https:\/\/doi.org\/10.3389\/fimmu.2021.794580","journal-title":"Front Immunol"},{"issue":"4","key":"3553_CR124","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/pharmaceutics13040508","volume":"13","author":"S Silva","year":"2021","unstructured":"Silva S, Almeida J (2021) Importance of nanoparticles for the delivery of antiparkinsonian drugs. Pharmaceutics 13(4):508","journal-title":"Pharmaceutics"},{"key":"3553_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.00757","volume":"9","author":"SS Singh","year":"2018","unstructured":"Singh SS, Rai SN, Birla H et al (2018) Effect of chlorogenic acid supplementation in MPTP-intoxicated mouse. Front Pharmacol 9:1\u201315. https:\/\/doi.org\/10.3389\/fphar.2018.00757","journal-title":"Front Pharmacol"},{"issue":"2","key":"3553_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6571484","volume":"2020","author":"SS Singh","year":"2020","unstructured":"Singh SS, Rai SN, Birla H et al (2020) Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of da neurons in a parkinsonian mouse model. Oxid Med Cell Longev 2020(2):1\u201314. https:\/\/doi.org\/10.1155\/2020\/6571484","journal-title":"Oxid Med Cell Longev"},{"key":"3553_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113958","volume":"156","author":"N Singh","year":"2022","unstructured":"Singh N, Singh V, Rai SN et al (2022) Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes. Biomed Pharmacother 156:113958. https:\/\/doi.org\/10.1016\/j.biopha.2022.113958","journal-title":"Biomed Pharmacother"},{"key":"3553_CR127","doi-asserted-by":"crossref","unstructured":"Singh N, Dkhar DS, Chandra P (2023) Nanobiosensors design using 2D materials: implementation in infectious and fatal disease diagnosis","DOI":"10.3390\/bios13020166"},{"key":"3553_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-022-00427-0","author":"P Stathis","year":"2022","unstructured":"Stathis P, Papadopoulos G (2022) Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson\u2019s disease. J Patient-Reported Outcomes. https:\/\/doi.org\/10.1186\/s41687-022-00427-0","journal-title":"J Patient-Reported Outcomes"},{"key":"3553_CR129","unstructured":"Stoker TB, Barker RA, Van Geest Centre J, Repair B (2020) Open Peer Review Recent developments in the treatment of Parkinson\u2019s Disease [version 1; peer review: 2 approved]. 9:1\u201312"},{"key":"3553_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13564-w","author":"T Stroh\u00e4ker","year":"2019","unstructured":"Stroh\u00e4ker T, Jung BC, Liou S et al (2019) Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-13564-w","journal-title":"Nat Commun"},{"key":"3553_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415922","author":"Z \u0160tukovnik","year":"2022","unstructured":"\u0160tukovnik Z, Bren U (2022) Recent developments in electrochemical-impedimetric biosensors for virus detection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232415922","journal-title":"Int J Mol Sci"},{"key":"3553_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-019-0106-4","author":"JYY Szeto","year":"2020","unstructured":"Szeto JYY, Walton CC, Rizos A et al (2020) Dementia in long-term Parkinson\u2019s disease patients: a multicentre retrospective study. NPJ Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/s41531-019-0106-4","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"3553_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101649","author":"JSY Tan","year":"2022","unstructured":"Tan JSY, Lee B, Lim J et al (2022a) Parkinson\u2019s disease-specific autoantibodies against the neuroprotective co-chaperone STIP1. Cells. https:\/\/doi.org\/10.3390\/cells11101649","journal-title":"Cells"},{"key":"3553_CR134","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JPD-212976","volume":"12","author":"YY Tan","year":"2022","unstructured":"Tan YY, Jenner P, Di CS (2022b) Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future. J Parkinson\u2019s Dis 12:477\u2013493. https:\/\/doi.org\/10.3233\/JPD-212976","journal-title":"J Parkinson\u2019s Dis"},{"key":"3553_CR135","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/10717544.2019.1636420","volume":"26","author":"S Tang","year":"2019","unstructured":"Tang S, Wang A, Yan X et al (2019) Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson\u2019s disease. Drug Delivery 26:700\u2013707. https:\/\/doi.org\/10.1080\/10717544.2019.1636420","journal-title":"Drug Delivery"},{"key":"3553_CR136","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC et al (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"3553_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14050987","volume":"14","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Preda MD, Niculescu AG et al (2022) Current strategies to enhance delivery of drugs across the blood-brain barrier. Pharmaceutics 14:1\u201330. https:\/\/doi.org\/10.3390\/pharmaceutics14050987","journal-title":"Pharmaceutics"},{"issue":"12","key":"3553_CR138","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/polym12123055","volume":"12","author":"S Thangudu","year":"2020","unstructured":"Thangudu S, Cheng F, Su C (2020) Advancements in the blood\u2013brain barrier penetrating nanoplatforms for brain related disease diagnostics. Polymers 12(12):3055","journal-title":"Polymers"},{"key":"3553_CR139","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2.Challenges","volume":"20","author":"E Tolosa","year":"2022","unstructured":"Tolosa E, Garrido A, Scholz SW et al (2022) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2.Challenges","journal-title":"Lancet Neurol"},{"key":"3553_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0110-8","author":"J Tran","year":"2020","unstructured":"Tran J, Anastacio H, Bardy C (2020) Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells. NPJ Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/s41531-020-0110-8","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"3553_CR141","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/ana.26187","volume":"90","author":"A Verger","year":"2021","unstructured":"Verger A, Grimaldi S, Ribeiro MJ et al (2021) Single photon emission computed tomography\/positron emission tomography molecular imaging for Parkinsonism: a fast-developing field. Ann Neurol 90:711\u2013719. https:\/\/doi.org\/10.1002\/ana.26187","journal-title":"Ann Neurol"},{"key":"3553_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-022-00425-5","author":"P Wal","year":"2022","unstructured":"Wal P, Dwivedi J, Wal A et al (2022) Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson \u2019 s disease and its medications. Future J Pharm Sci. https:\/\/doi.org\/10.1186\/s43094-022-00425-5","journal-title":"Future J Pharm Sci"},{"key":"3553_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2020.603793","volume":"12","author":"B Wang","year":"2021","unstructured":"Wang B, Liu X, Xu S et al (2021) Sporadic Parkinson\u2019s disease potential risk loci identified in han ancestry of Chinese Mainland. Front Aging Neurosci 12:1\u201314. https:\/\/doi.org\/10.3389\/fnagi.2020.603793","journal-title":"Front Aging Neurosci"},{"key":"3553_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/bios12121094","author":"J Wang","year":"2022","unstructured":"Wang J, Davidson JL, Kaur S et al (2022) Paper-based biosensors for the detection of nucleic acids from pathogens. Biosensors. https:\/\/doi.org\/10.3390\/bios12121094","journal-title":"Biosensors"},{"key":"3553_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2020.581191","volume":"14","author":"S Wen","year":"2020","unstructured":"Wen S, Aki T, Unuma K, Uemura K (2020) Chemically induced models of Parkinson\u2019s disease: history and perspectives for the involvement of ferroptosis. Front Cell Neurosci 14:1\u201316. https:\/\/doi.org\/10.3389\/fncel.2020.581191","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"3553_CR146","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","volume":"25","author":"AA Yetisgin","year":"2020","unstructured":"Yetisgin AA, Cetinel S, Zuvin M et al (2020) Therapeutic nanoparticles and their targeted delivery applications. Molecules 25(9):2193","journal-title":"Molecules"},{"key":"3553_CR147","first-page":"1","volume":"01017","author":"H You","year":"2022","unstructured":"You H (2022) The new developing treatment of Parkinson\u2019s disease. EDP Sci 01017:1\u20135","journal-title":"EDP Sci"},{"key":"3553_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16790-8","author":"Q Yu","year":"2018","unstructured":"Yu Q, Yu S, Zuo L et al (2018) Parkinson disease with constipation: clinical features and relevant factors. Sci Reports. https:\/\/doi.org\/10.1038\/s41598-017-16790-8","journal-title":"Sci Reports"},{"key":"3553_CR149","unstructured":"Zahoor I, Shafi A, Haq E (2018) Parkinson\u2019s Disease (book) inc animal model review"},{"key":"3553_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/bios12070473","author":"NS Zambry","year":"2022","unstructured":"Zambry NS, Obande GA, Khalid MF et al (2022) Utilizing electrochemical-based sensing approaches for the detection of SARS-CoV-2 in clinical samples: a review. Biosensors. https:\/\/doi.org\/10.3390\/bios12070473","journal-title":"Biosensors"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-023-03553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-023-03553-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-023-03553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:26:46Z","timestamp":1744201606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13205-023-03553-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":151,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1007\/s13205-023-03553-8","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable as this study has not involved any animal or human.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for Publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"142"}}